Commerzbank set a €87.00 ($107.41) price target on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research report report published on Friday, February 16th. The firm currently has a neutral rating on the stock.

Several other analysts have also commented on FME. Berenberg Bank set a €95.60 ($118.02) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research report on Thursday, November 2nd. Kepler Capital Markets set a €95.00 ($117.28) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research report on Thursday, November 2nd. S&P Global set a €95.00 ($117.28) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research report on Monday, November 6th. Goldman Sachs Group set a €97.00 ($119.75) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research report on Monday, November 6th. Finally, JPMorgan Chase & Co. set a €95.60 ($118.02) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research report on Tuesday, December 5th. Ten analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The stock has a consensus rating of Buy and an average target price of €92.27 ($113.91).

Fresenius Medical Care AG & Co. KGaA (ETR:FME) traded down €0.92 ($1.14) during mid-day trading on Friday, reaching €82.24 ($101.53). The company’s stock had a trading volume of 963,338 shares, compared to its average volume of 702,385. The firm has a market cap of $25,340.00 and a P/E ratio of 19.67. Fresenius Medical Care AG & Co. KGaA has a fifty-two week low of €75.53 ($93.25) and a fifty-two week high of €93.82 ($115.83).

COPYRIGHT VIOLATION NOTICE: “Fresenius Medical Care AG & Co. KGaA (ETR:FME) Given a €87.00 Price Target at Commerzbank” was published by Marea Informative and is the sole property of of Marea Informative. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.mareainformativa.com/2018/03/14/fresenius-medical-care-ag-87-00-price-target-at-commerzbank-updated-updated-updated.html.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.